Cargando…
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
In October 2020, the National Cancer Institute (NCI) Serological Sciences Network (SeroNet) was established to study the immune response to COVID-19, and “to develop, validate, improve, and implement serological testing and associated technologies” (https://www.cancer.gov/research/key-initiatives/co...
Ejemplares similares
-
The Serological Sciences Network (SeroNet) for COVID-19: Depth and Breadth of Serology Assays and Plans for Assay Harmonization
por: Karger, Amy B., et al.
Publicado: (2022) -
Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies
por: Figueiredo, Jane C, et al.
Publicado: (2022) -
The SeroNet Clinical and Translational Serology Task Force (CTTF) SARS-CoV-2 mucosal immunity methodological considerations and best practices workshop
por: Hempel, Heidi, et al.
Publicado: (2023) -
The HPV Serology Laboratory leads an initiative to standardize and harmonize human papillomavirus serology assays
por: Park, Isabel, et al.
Publicado: (2023) -
Clinical Utility of SARS-CoV-2 Serological Testing and Defining a Correlate of Protection
por: Sobhani, Kimia, et al.
Publicado: (2023)